| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8653309 | Annals of Vascular Surgery | 2018 | 6 Pages |
Abstract
CHs remain a marginal salvage conduit in the setting of infection and no autogenous choices. Therefore, clinicians should individualize usage of this high-cost product in highly selected patients only.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
S. Keisin Wang, Ashley R. Gutwein, Natalie A. Drucker, Michael P. Murphy, Andres Fajardo, Michael C. Dalsing, Raghu L. Motaganahalli, Gary W. Lemmon,